Stage-independent expression and genetic analysis oftp73 in neuroblastoma
Massimo Romani(Ospedale Policlinico San Martino), Gian Paolo Tonini(Città della Speranza Foundation), Katia Mazzocco(Istituto Giannina Gaslini), Ida Casciano(Alleanza Contro il Cancro), Paola Scaruffi(Azienda Ospedaliera S.Maria), Luca Boni(Ospedale Policlinico San Martino), Bruno De Bernardi(Istituto Giannina Gaslini), Andrea Cavazzana(University of Rome Tor Vergata), Crocifissa Lo Cunsolo(Istituto Giannina Gaslini), Claudio Gambini(Istituto Giannina Gaslini)
International Journal of Cancer
August 20, 1999
Cited by 15
Related Papers
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
|The Lancet Oncology|2015|1.1k
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
|New England Journal of Medicine|2014|1.1k
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
|Journal of Clinical Oncology|2011|763
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.
|Journal of Clinical Oncology|1988|608